Literature DB >> 25155559

Profiles of orofacial dysfunction in different diagnostic groups using the Nordic Orofacial Test (NOT-S)--a review.

Birgitta Bergendal1, Merete Bakke, Anita McAllister, Lotta Sjögreen, Pamela Åsten.   

Abstract

OBJECTIVE: The Nordic Orofacial Test-Screening (NOT-S) was developed as a comprehensive method to assess orofacial function. Results from the screening protocol have been presented in 11 international publications to date. This study reviewed these publications in order to compile NOT-S screening data and create profiles of orofacial dysfunction that characterize various age groups and disorders.
MATERIALS AND METHODS: NOT-S results of nine reports meeting the inclusion criteria were reviewed. Seven of these studies not only provided data on the mean and range of total NOT-S scores, but also on the most common domains of orofacial dysfunction (highest rate of individuals with dysfunction scores), allowing the construction of orofacial dysfunction profiles based on the prevalence of dysfunction in each domain of NOT-S.
RESULTS: The compiled data comprised 669 individuals, which included healthy control subjects (n = 333) and various patient groups (n = 336). All studies reported differences between individuals with diagnosed disorders and healthy control subjects. The NOT-S data could measure treatment effects and provided dysfunction profiles characterizing the patterns of orofacial dysfunction in various diagnoses.
CONCLUSIONS: This review corroborates previous results that the NOT-S differentiates well between patients and healthy controls and can also show changes in individuals after treatment. NOT-S could be used as a standard instrument to assess orofacial dysfunction, evaluate the outcomes of oral habilitation and rehabilitation and improve comparability in clinical practice and research.

Entities:  

Keywords:  chewing; oral disability; rare disorders; screening; speech

Mesh:

Year:  2014        PMID: 25155559     DOI: 10.3109/00016357.2014.942874

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  7 in total

1.  Association of orofacial dysfunction and sleep disordered breathing among Indian primary school children.

Authors:  Deepa Metgud; Punnya V Angadi; Anjana Panthee
Journal:  J Oral Biol Craniofac Res       Date:  2022-08-13

2.  Assessment of orofacial dysfunction using the NOT-S method in a group of Turkish children with cerebral palsy.

Authors:  Alev Alaçam; Buket Ceylan Çalık Yılmaz; Arzu Sukran Incioğlu
Journal:  Eur Arch Paediatr Dent       Date:  2019-09-06

3.  Impact of early childhood caries and its treatment under general anesthesia on orofacial function and quality of life : A prospective comparative study.

Authors:  V Collado; H Pichot; C Delfosse; C Eschevins; E Nicolas; M Hennequin
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-05-01

4.  Children and adolescents with speech sound disorders are more likely to have orofacial dysfunction and malocclusion.

Authors:  Åsa Mogren; Anders Sand; Christina Havner; Lotta Sjögreen; Anna Westerlund; Monica Barr Agholme; Anita Mcallister
Journal:  Clin Exp Dent Res       Date:  2022-06-20

5.  Sublingual administration of atropine eyedrops in children with excessive drooling - a pilot study.

Authors:  Johanna Norderyd; Jonas Graf; Agneta Marcusson; Karolina Nilsson; Eva Sjöstrand; Gunilla Steinwall; Elinor Ärleskog; Mats Bågesund
Journal:  Int J Paediatr Dent       Date:  2015-12-27       Impact factor: 3.455

6.  Study of Orofacial Function in Preschool Children Born Prematurely.

Authors:  Mei-Chen Chang; Hsiu-Yueh Liu; Shun-Te Huang; Hsiu-Lin Chen
Journal:  Children (Basel)       Date:  2022-03-04

7.  Rare Disorders: Diagnosis and Therapeutic Planning for Patients Seeking Orthodontic Treatment.

Authors:  Carolina Arriagada-Vargas; María Teresa Abeleira-Pazos; Mercedes Outumuro-Rial; Eliane García-Mato; Iván Varela-Aneiros; Jacobo Limeres-Posse; Pedro Diz-Dios; Márcio Diniz-Freitas
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.